OCT 20, 2020 7:30 AM PDT

Non-coding RNA As A Barometer For Liver Health

WRITTEN BY: Tara Fernandez

October is liver cancer awareness month — a month dedicated to educating people about the risk factors and preventative measures associated with the disease. In the United States, around 30,000 individuals are affected annually. As with all cancers, health organizations advocate for screening and early detection to improve patient outcomes. But what if current diagnostic technologies are unable to pick up signs of malignancies at the early stages?

Due to the lack of reliable liver cancer biomarkers, physicians typically use imaging technologies like ultrasounds or CT tests to look for signs of malignant tissues. Liver biopsies are highly invasive and, consequently, are rarely taken. Instead, the detection of abnormalities is usually followed up with surgery to remove the suspected tumor. 

A study published recently in the Journal of Cancer Research and Clinical Oncology details a promising new way of detecting liver cancer. Scientists have discovered a molecule named HELIS (short for HEalthy LIver Specific), a novel liver cancer biomarker. Unlike cancer biomarkers that point to the presence of disease; however, detecting HELIS in a patient sample actually means that the liver is healthy.

Study lead Olga Burenina explains, "Many classical tumor markers do not always show up in the case of cancer or may have elevated levels due to noncancerous diseases, such as cirrhosis or hepatitis in the case of the liver.” 

“The 'healthy liver' markers can be more informative because if a 'malfunction' occurs in the cancer cells and, for example, HELIS are no longer produced as they should, the problem may not be fixed that easily."

HELIS is a non-coding RNA — an RNA molecule that orchestrates physiological processes inside the cell. Burenina and the team used postoperative samples of six different types of liver tumors to validate the use of HELIS as a biomarker. 

Measurements of HELIS in these samples showed how remarkably reliable this molecule is as a biomarker of poor liver health: HELIS levels dropped to sometimes completely undetectable levels in all the tumor samples. A panel of four non-coding RNAs, including HELIS, was subsequently designed, which together could help differentiate between healthy and malignant liver tissues and even potentially diagnose specific types of liver cancer.

Sources: Journal of Cancer Research and Clinical Oncology, Medical Xpress.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 17, 2020
Microbiology
Ingestible Bacteria-Catcher Could Act as a Diagnostic Tool
AUG 17, 2020
Ingestible Bacteria-Catcher Could Act as a Diagnostic Tool
Microbes in our gastrointestinal tract may not only be closely linked to our health, but they may also be useful as a di ...
AUG 18, 2020
Clinical & Molecular DX
DIY COVID Tests Instead of Vaccines?
AUG 18, 2020
DIY COVID Tests Instead of Vaccines?
Routine, do-it-yourself COVID-19 testing could be just as good as a vaccine when it comes to stopping the transmission o ...
AUG 27, 2020
Clinical & Molecular DX
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
AUG 27, 2020
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
  Many diseases such as breast cancer have both a strong genetic component, coupled with a variety of environmental ...
SEP 07, 2020
Clinical & Molecular DX
Spot the Robodog Measures COVID Patients' Vitals
SEP 07, 2020
Spot the Robodog Measures COVID Patients' Vitals
Hospital staff caring for COVID-19 patients face the greatest risk of exposure to the virus. A new dog-like robot design ...
NOV 03, 2020
Genetics & Genomics
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
NOV 03, 2020
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr ...
NOV 14, 2020
Cannabis Sciences
Half of CBD Users Test Positive for THC in Urine Tests
NOV 14, 2020
Half of CBD Users Test Positive for THC in Urine Tests
Despite the growing popularity of cannabidiol (CBD) products, there has been little research directly assessing whether ...
Loading Comments...